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Abstract
Doctors and their patients are always concerned with the likely outcome of an existing disease and
the risk of future diseases, but there are many problems in interpreting for the individual data
derived from populations. Yet recent developments in mathematics and science should allow us to
do much better.
Editorial
An individual patient is not the average representative of
the population. Rather he or she is a person with unique
characteristics. An intervention may be effective for a pop-
ulation but not necessarily for the individual patient. The
recommendation of a guideline may not be right for a par-
ticular patient because it is not what he or she wants, and
implementing the recommendation will not necessarily
mean a favourable outcome.
Clinical epidemiology and medical statistics are not
suited to answer specific questions at the individual level.
They focus on groups of individuals and not on single
individuals. Classical statistics by definition needs sam-
ples to work, and samples by definition are always greater
than one. This explains why is it almost impossible to per-
form any kind of statistics in the single individual. But
despite these limitations physicians are forced to transfer
statistical concepts emerging from groups to single indi-
viduals with deficiencies that the patient (and even the
doctor) do not always understand. As Michael Kattan
wrote in a famous editorial the patient who is in front of
us may increasingly often say: "I am a patient, not a statis-
tic!" [1].
Evidence based medicine, which is a natural product of
classical statistics and randomized clinical trials, has led to
the development of management protocols that are the
best compromise for a group of patients defined in a cer-
tain way. But when abstract guidelines "hit" real patient
care experience clearly shows that (with very few excep-
tions) no protocol fits every patient; and, more impor-
tantly, no protocol fits any patient perfectly.
Clinicians need measures of outcomes among individual
patients during a trial as well as during routine clinical
activity, especially when they expect considerable varia-
tion in the outcome. A confidence interval is inadequate
for the clinician to decide what the useful the results of a
megatrial will mean in clinical practice. Average results
and confidence intervals from megatrials conceal huge
diversity among the results for individual subjects.
The narrow confidence intervals generated by megatrials
(and even more so by meta-analyses) are often under-
stood to mean that doctors can be confident that the esti-
mates of therapeutic effectiveness are valid and accurate.
This is untrue both in the narrowly statistical sense as well
as in the broad clinical sense. In fact the confidence inter-
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vals give no indication of the precision of an estimate for
an individual in a trial. Furthermore, the narrowness of a
confidence interval does not have any relation to a possi-
ble causal relation. Nor does it give any indication of the
applicability of a trial result to another population. A
resulting paradox is that narrow, non-overlapping confi-
dence intervals that discriminate sharply between proto-
cols in a statistical sense may, nevertheless, be associated
with a variation among subjects such that some patients
may be harmed by a treatment that benefits the majority.
We know that any kind of statistical inference is extremely
weak in the absence of a "sample", which by definition
requires a number greater than one. For this reason pre-
dictive models can fail dramatically when applied to the
single individual. In a model that has an overall 90%
accuracy in predicting an event on a group level, the
degree of confidence can drop substantially when applied
to a single subject.
Suppose that a predictive model for risk assessment in
study data has been developed and validated and that it
allows an overall accuracy of 0.9. Suppose that the confi-
dence interval of this predictive rate is 0.06 (0.84–0.96).
The first step is to assess a group of new subjects with our
tools. We can reasonably expect to make classification
mistakes within a range of 4%–16%. Therefore 4 to 16 of
100 new patients would be incorrectly assessed with
regard to their absolute risk. If a new patient has been clas-
sified as at high risk to suffer from myocardial infarction
in the next 10 years, the patient might think that there is a
90% chance that he or she has been correctly classified
(84% at worst and 96% at best). Unfortunately the
patient's confidence interval in this classification would
not be equal to that of the group since with misclassifica-
tion the patient could have either a correct prognosis or
incorrect prognosis – a 100% difference.
One of the major challenges to delivering effective treat-
ment is to devise a method capable of determining the
confidence interval of a single individual.
This would be possible by feeding the data into artificial
adaptive systems based on recursive algorithms that can
solve problems that are not accessible to classical statis-
tics. The findings from this new field of network mapping
allow us to know what until now would have been science
fiction. With a large data set it is theoretically possible to
find individuals within the original population who are
closest to our subject according to all descriptive parame-
ters. This is feasible through non-linear mapping with spe-
cific evolutionary algorithms.
Taking into account all the descriptors available we
should be able to match our subject with a suitable sub-
group of subjects or even to another single subject. If we
succeed in doing so we could take advantage of the statis-
tics of a group to benefit the single individual. Unfortu-
nately the problem is not simple. Suppose that the
reference population is 1000 individuals and each indi-
vidual is described by 50 variables. Finding a single indi-
vidual who is most similar to the subject on study
according to all variables means a non-polynomial time
computation problem in which there are
36048possibilities to check. Even with the most powerful
computer the time needed for such an analysis would be
beyond any practical possibility.
The PST (Pick and Squash Tracking) is an evolutionary
algorithm able to find the best spatial distribution of a
given number of "objects" (in our case human subjects)
described by a given number of variables. The number of
subjects and variables can be very high, but despite this
the algorithm is able to cope with explosive growing of
dimensionality of the observation vector. The trick is to
respect at maximum degree the "distances" of the objects
among each other in the multidimensional space without
exploring all the possible combinations but adaptively
evolving through the optimal solution [2]. This avoids the
so-called "curse of dimensionality". To be mathematically
precise the PST algorithm carries out a multidimensional
scaling from an N dimensional to a L dimensional space
(where N>>L) and typically where L = 2 or L = 3. PST acts
in this dimensional reduction to ensure that the original
distance between points has the minimal amount of dis-
tortion in the L- dimensional space. In the case in which
N< = L this distortion approaches zero. PST carries out this
type of projection by means of an evolutionary algorithm
called GenD [3], specifically defined to achieve this aim.
Pilot experiences in medicine are already available and
seem quite encouraging [4,5].
This is probably the point at which most doctors begin to
feel uncomfortable with the mathematics, but for those
who want more I've appended a mathematical explana-
tion. But what all this means is that we begin to have a
method to go beyond populations to individuals when
advising patients. This will be a very important develop-
ment.
Appendix
From the mathematical point of view the problem can be
presented in the following form: given K points X = {x1,
...., xk}, or their distances in a N-dimensional space, find
the distribution of these points Y = {y1, ...., yk} in a L-
dimensional space with L<N, so that we minimize the
"difference" between the original distances and those in
the projected space.
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the matrix of the map distances Md(Y): Mdij = DL(yi, yi),
the matrix of the original distances Rd(X): Rdij = DN(xi, xj),
and a measure of the dissimilarity between the two matri-
ces E = E(Md, Rd),
then the target function consists in finding a configuration
of points Y' = {y'1, ...., y'N}, such that:
E* = min [E(Md(Y'), Rd(X))] (1)
Typically, the Error on the map, Md(Y), is calculated using
the Euclidean distance:
This distance is dynamically adjusted during the Pst evo-
lution, to minimize the Error Function of the problem( E*
= min [E(Md(Y'), Rd(X))]).
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